Biodesix Corp - BDSX Net earnings per share (EPS TTM)

Biodesix Inc (BDSX) - corporate logo

EPS dynamics, as reflected in the asset value chart, illustrate the efforts of Biodesix, Inc. (BDSX) to expand its B2B partner network and implement precision lung tests. However, slow adoption of these methods by insurance companies limits cash inflows, with the indicator standing at 48.00. High marketing expenses and competitive pressure create barriers to break-even, intensifying the risks of a prolonged operating deficit.

Biodesix Corp (BDSX) - Net earnings per share for the last 12 months from 02/11/2024 to 11/17/2026

biodesix.com - analytical breakdowns and key metrics (BDSX)

- share price and consensus valuation forecast:
Initial company analysis:BDSX (Biodesix)
Original product of Biodesix, Inc.

This indicator measures the dynamics of the rolling annual earnings per share, allowing for an assessment of net income scaling rates and cash flow sustainability. By analyzing the historical delta of eps YoY ttm, an investor can see how stable demand for Biodesix, Inc. biotechnologies shields the business from macroeconomic shocks, confirming the company's status as a reliable defensive asset.